Clinical Trials Sponsored by COUR Pharmaceutical Development Company, Inc.

Total 560 results

COUR Pharmaceutical Development Company, Inc.

Recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Myasthenia Gravis | Generalized Myasthenia | AChR Myasthenia Gravis | MuSK MG

United States
COUR Pharmaceutical Development Company, Inc.

Terminated

CNP-201 in Subjects With Peanut Allergy

Peanut Allergy

United States
COUR Pharmaceutical Development Company, Inc.

Terminated

Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy

Peanut Allergy

United States
COUR Pharmaceutical Development Company, Inc.

Active, not recruiting

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States
Takeda
COUR Pharmaceutical Development Company, Inc.

Completed

Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease

Celiac Disease

United States
Takeda
COUR Pharmaceuticals Development Company, Inc.

Completed

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease

Celiac Disease

United States
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

cUTI

United States, Latvia, Poland, Czechia, Romania, Ukraine, Russian Federation, Georgia, Colombia, Bulgaria, Estonia, Greece, Hungary, Israel, Italy, Mexico, Moldova, Republic of, South Africa
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections (IGNITE3)

Complicated Urinary Tract Infections

Ukraine, United States, Bulgaria, Romania, Estonia, Russian Federation, Hungary, Austria, Slovakia, Latvia, Moldova, Republic of, Georgia
Tetraphase Pharmaceuticals, Inc.

Completed

A Safety and PK Study of IV Eravacycline

Bacterial Infections

United States
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections (IGNITE1)

Complicated Intra-abdominal Infections

United States, France, Ukraine, Argentina, Bulgaria, Romania, South Africa, Germany, Estonia, Russian Federation, Lithuania, Czechia, Latvia
Tetraphase Pharmaceuticals, Inc.

Completed

Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections

Complicated Intra-abdominal Infection

United States, Latvia, Lithuania, Romania, India, Bulgaria
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections (IGNITE4)

Complicated Appendicitis | Complicated Intra-abdominal Infections

Ukraine, United States, Bulgaria, Romania, Estonia, Russian Federation, Lithuania, Hungary, Latvia, Georgia, Czechia
Tetraphase Pharmaceuticals, Inc.

Completed

A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization

Normal Healthy Subjects
Tetraphase Pharmaceuticals, Inc.

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects

Impaired Hepatic Function

United States
Tetraphase Pharmaceuticals, Inc.

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

End Stage Renal Disease
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer

Pain | Advanced Cancer

Israel, Italy, Taiwan, United Kingdom, Bulgaria, Hungary, India, Australia, Lithuania, Poland, Spain, Romania, Germany
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Pain | Advanced Cancer

Italy, United States, Taiwan, United Kingdom, Czechia, Bulgaria, Belgium, Latvia, Mexico, Lithuania, Poland, Romania, Hungary, Spain, Israel, Germany, Puerto Rico, Australia
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer (SPRAY III)

Pain | Advanced Cancer

United States, Germany, United Kingdom, Mexico, Poland, Romania, Bulgaria, Czechia, Hungary, Puerto Rico
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

Pain | Advanced Cancer

United States, United Kingdom, Bulgaria, Belgium, Poland, Hungary, Romania, Czechia, Puerto Rico, Lithuania, Germany, Latvia
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Study of Qualaquin and Midazolam

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Comparison Bioavailability Study of Quinine Sulfate in Chocolate Pudding

Healthy

Canada
Mutual Pharmaceutical Company, Inc.

Completed

Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin

Healthy
Mutual Pharmaceutical Company, Inc.

Completed

A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice

Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Completed

Bioavailability Study of Colcrys® Crushed and Sprinkled on Applesauce

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets

Healthy | Therapeutic Equivalency
Mutual Pharmaceutical Company, Inc.

Completed

Bioavailability Study of Colcrys® in Apple Juice

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Bioavailability Study of Cilostazol Tablets, 50mg

Therapeutic Equivalency, Healthy
Mutual Pharmaceutical Company, Inc.

Completed

Pharmacokinetic Study of an Acute Gout Regimen

Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Completed

Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Study Between Colchicine and Cyclosporine

Healthy | Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Between Colchicine and Verapamil ER

Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Terminated

Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment

Healthy | Renal Impairment

United States
Mutual Pharmaceutical Company, Inc.

Completed

Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients

Familial Mediterranean Fever

Israel, Turkey, United States, Armenia
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Food Interaction Study of Seville Orange Juice and Colchicine

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Relative Bioavailability of Colcrys™ 0.6 mg Tablets in Healthy Young and Elderly Volunteers Under Fasted Conditions

Healthy
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Study Between Colchicine and Atorvastatin

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Study of Colchicine and Theophylline

Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Completed

Fed Bioavailability Study of Zonisamide Capsules

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Fed Bioavailability Study of Lovastatin Tablets and Mevacor Tablets

Healthy

Canada
Mutual Pharmaceutical Company, Inc.

Completed

Pharmacokinetic Study With Colchicine in Healthy Volunteers

Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Completed

Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)

Healthy
Mutual Pharmaceutical Company, Inc.

Completed

Four Arm Food Effect Study of Fenofibric Acid Tablets

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Study Between Colchicine and Ketoconazole

Pharmacokinetics

United States
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Study of Colchicine and Clarithromycin

Pharmacokinetics

United States
Nastech Pharmaceutical Company, Inc.

Completed

A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects

Obesity

United States
Nastech Pharmaceutical Company, Inc.

Completed

A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients

Diabetes Mellitus

United States
Nastech Pharmaceutical Company, Inc.

Withdrawn

Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD

Osteoporosis | Osteopenia
Mutual Pharmaceutical Company, Inc.

Completed

Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz

Healthy
Mutual Pharmaceutical Company, Inc.

Completed

A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Pharmacokinetic and Bioequivalency Study of Fenofibric Acid

Healthy

Clinical Trials Sponsored by COUR Pharmaceutical Development Company, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations